Stephen DeCherney is a doctor, professor of medicine, and business executive.
He’s named one of the Best Doctors in America and is board certified in Internal Medicine and Endocrinology, Diabetes and Metabolism.
As a researcher, his background includes four and a half years at the National Institutes of Health, and as a principal investigator for more than 100 critical trials at the Christiana Care Health System in Wilmington, Delaware, where he remains a trustee.
A professor of medicine and professor of business at the University of North Carolina, Chapel Hill, he’s previously taught at the University of Delaware and Thomas Jefferson University. He also serves as Chair of the University of Delaware Research Foundation.
In business, DeCherney DeCherney is a Director of Health Decisions, Inc. He is currently a Senior Advisor to Anagenesis Capital Partners, Inc. He worked at Quintiles Transnational Corporation, as President, Global Clinical Research Organization and Chief Innovation Officer, and at PRA International, as Executive Vice President of Global Clinical Operations.
DeCherney was previously an independent Director of Theorem Clinical Research Company. He was also a trustee of the William Harvey Research Institute, of the Queen Mary Medical College, St. Barts and the London Hospitals, University of London. He was only one of two American senior advisors of the London School of Hygiene and Tropical Medicine. He was also a senior advisor to the London Genetics Company.
DeCherney received a B.A. in Biology from Columbia College. He was awarded the Columbia College Alumni Achievement Award granted to the “Senior Adjudged Most Outstanding in Qualities of Mind, Character, and Service to the College.” He received his medical degree from Temple University in Philadelphia, and completed his internal medicine residency at the Graduate Hospital of the University of Pennsylvania. DeCherney received his endocrinology training at Vanderbilt University and a Master’s in Public Health from Columbia.